The GnRH receptor (GnRHR) is expressed in several non-pituitary tissues, notably in gonads. However, mechanisms underlying the gonad-specific expression of Gnrhr are not well understood. Here, Gnrhr expression was analysed in the developing testes and pituitaries of rats and transgenic mice bearing the human placental alkaline phosphatase reporter gene (ALPP) under the control of the rat Gnrhr promoter. We showed that the 3.3 kb, but not the pituitary-specific 1.1 kb promoter, directs ALPP expression exclusively to testis Leydig cells from embryonic day 12 onwards. Real-time PCR analysis revealed that promoter activity displayed the same biphasic profile as marker genes in Leydig cells, i.e. abrupt declines after birth followed by progressive rises after a latency phase, in coherence with the differentiation and evolution of foetal and adult Leydig cell lineages. Interestingly, the developmental profile of transgene expression showed high similarity with the endogenous Gnrhr profile in the rat testis, while mouse Gnrhr was only poorly expressed in the mouse testis. In the pituitary, both transgene and Gnrhr were co-expressed at measurable levels with similar ontogenetic profiles, which were markedly distinct from those in the testis. Castration that induced pituitary Gnrhr up-regulation in rats did not affect the mouse Gnrhr. However, it duly up-regulated the transgene. In addition, in LbT2 cells, the rat, but not mouse, Gnrhr promoter was sensitive to GnRH agonist stimulation. Collectively, our data highlight inter-species variations in the expression and regulation of Gnrhr in two different organs and reveal that the rat promoter sequence contains relevant genetic information that dictates rat-specific gene expression in the mouse context.
Introduction
The interaction of hypothalamic GnRH with a specific G protein-coupled receptor (GnRHR) present at the surface of pituitary gonadotrope cells is critical to the neuroendocrine regulation of the reproductive axis in all vertebrates (Stojilkovic et al. 1994 , Millar et al. 2004 , Counis et al. 2005 . GnRH-binding activity and Gnrhr mRNA expression have also been identified in a variety of non-pituitary tissues and notably in those linked to reproduction. These include ovary, placenta, mammary gland and endometrium in the female as well as prostate and testis in the male (Ramakrishnappa et al. 2005) . In these tissues, a local production of GnRH supports potential auto-or paracrine modulation of cell functions by GnRHR, as illustrated by the archetypal rat gonads (Clayton & Catt 1981 , Scott et al. 2009 . Little is known about the mechanisms and factors governing the expression of Gnrhr in non-pituitary tissues. Most studies have indeed focused on the pituitary gland, mainly in rats, mice and humans. Within the promoters of these species, several response elements and related transcription factors involved in the gonadotrope-specific and regulated expression of pituitary Gnrhr have been identified (Pincas et al. 1998 , Jorgensen et al. 2004 , Hapgood et al. 2005 , Granger et al. 2006 , Schang et al. 2013a . Studies of these promoters in the ovary, placenta and hippocampus indicate that Gnrhr expression is driven by the same promoter with, however, different response elements and sets of transcription factors (Kang et al. 2000 , Cheng et al. 2002 , Schang et al. 2011b , 2013b .
In mammals, Leydig cells originate from at least two generations of cells (Lejeune et al. 1998 , O'Shaughnessy et al. 2005 . The first generation, known as 'foetal', develops during foetal life soon after testis differentiation, at about 12.5 days post-conception (dpc) in mice. These cells are essential for masculinisation of the male urogenital system and have been described either to regress or to be maintained in the adult (Habert et al. 2001) . The second cell population, termed 'adult', appears before puberty and produces testosterone required for the onset of spermatogenesis and the maintenance of reproductive function. To date, based on functional and morphological criteria, it is believed that these two cell populations represent two distinct lineages (O'Shaughnessy et al. 2006) . Using RT-PCR approaches in rat foetal gonads, we have previously identified Gnrh and Gnrhr transcripts as soon as 14.5 dpc (Botte et al. 1998) . Interestingly, the foetal expression pattern of Gnrhr in the testis displayed an acute rise at late gestation starting at 20.5 dpc that corresponds to the onset of testis responsiveness to GnRH (Habert et al. 1991 , Habert 1992 ). The precise localisation of Gnrhr expression and whether it was restricted to the Leydig cell population during foetal development was not examined in these studies. Moreover, to our knowledge, no data exist so far regarding the postnatal evolution of testicular Gnrhr expression and correlation with Leydig cell differentiation, as reported for the pituitary gonadotrope lineage (Wilson & Handa 1997 , Zapatero-Caballero et al. 2003 , Granger et al. 2004 .
In this study, we examined the developmental pattern of Gnrhr expression in the rat and mouse testis taking advantage of transgenic mice bearing the rat Gnrhr promoter fused to a highly sensitive reporter gene, the human placental alkaline phosphatase gene (ALPP). These transgenic mice were initially generated to improve in vitro analyses of the mechanisms involved in promoter activity and, most importantly, to explore, in vivo, the developmental pattern of rat Gnrhr promoter activity in the pituitary (Pincas et al. 2001 , Granger et al. 2004 , Schang et al. 2013a . These transgenic mice also appeared to be powerful tools to identify novel tissues in which the Gnrhr promoter is active (Schang et al. 2011a (Schang et al. ,b, 2013b . Two transgenic mouse lines expressing ALPP under the control of the 3.3 or 1.1 kb rat Gnrhr promoter (referred to as 3.3-Gnrhr and 1.1-Gnrhr respectively) were generated. Transgene expression was directed to pituitary gonadotrope cells in both mouse lines, thus supporting our in vitro data in gonadotrope cell lines, indicating that the 1.1 kb promoter sequence was necessary and sufficient for pituitary-specific expression (Granger et al. 2004) . Recently, we have reported transgene expression in the testis (Schang et al. 2011a) .
These mouse models were used here to analyse the pattern of rat Gnrhr promoter activity during testis development and, most specifically, during Leydig cell differentiation, from foetal to adult stages. By combining in situ detection of the transgene, as reported previously (Schang et al. 2011a) , together with real-time RT-PCR, we showed that the 3.3 kb sequence of the rat Gnrhr promoter is capable of directing reporter gene expression in foetal as well as in adult Leydig cells. Interestingly, we found that the ontogenetic profile of transgene expression reflected the evolution of rat Gnrhr rather than endogenous Gnrhr, which was only weakly expressed in the mouse testis. Furthermore, in the pituitary, in which both transgene and endogenous Gnrhr displayed similar ontogenetic profiles, only the transgene was up-regulated after castration. Collectively, our data provide strong arguments indicating that the relatively short 3.3 kb sequence of the rat promoter encodes not only tissue-specific programmes but also species-specific instructions, which both predominate over the mouse environment.
Paris-Rive Gauche University (Agreement A75-1317), Centre National de la Recherche Scientifique and University Paris-Diderot Paris 7, Paris, France. Rats were from the Wistar strain (colony of Janvier, 53680 Le Genest, France). Transgenic mice were from our own colonies generated on site using classical microinjection techniques as described previously (Granger et al. 2004) . To time foetal development, males and females were caged overnight and the morning day when the vaginal plug was observed was designated as day 0 post-conception (dpc). The day of birth was designatedas day 0 postnatal (dpn). Pregnant animals were killed at the same hour of the day from 12 to 20 days post-conception (dpc) and foetuses removed for tissue collection. The sex of the foetuses was determined by gonadal morphological differences and the testes were dissected together with adjacent mesonephros in foetuses under 14 dpc, or without mesonephros above 14 dpc. In addition, the anterior pituitary was collected. For castration experiments, animals of both sexes were killed at 1000 h and randomly cycling females were used.
In situ analyses
Tissues were fixed 1 h (pituitary and embryonic testes) or 2 h (pre-pubertal and adult testes) in 2% paraformaldehyde and then processed according to previously described procedures (Guigon et al. 2003 , Granger et al. 2004 . Briefly, after washing in PBS-sucrose, tissues were embedded in Tissue-Tek OCT compound (Sakura/CML, Nemours, France) and 5 mm sections were cut on a CM1950 cryostat (Leica, Nussloch, Germany). The sections were mounted onto ten-well TESPA (3-aminopropyltriethoxysilane; Sigma)-coated medical diagnostic slides (Menzel-Glaser/CML, Nemours, France). For the detection of ALPP activity, slides were heated at 65 8C to denature endogenous phosphatases prior to incubation with a chromogenic enzyme substrate mixture containing nitro blue tetrazolium. Detection of HSD3b (3b-hydroxysteroid dehydrogenase enzyme) in Leydig cells was performed by using either histochemical staining with a chromogenic enzyme substrate mixture composed of blue tetrazolium, etiocholan-3b-ol-17-one and nicotinamide adenosine diphosphate in phosphate buffer (pH 7.2) (Collenot & Collenot 1977) , or immunostaining using a rabbit polyclonal antibody directed against mouse HSD3b (kindly provided by Dr P Robel, CHU Bicêtre, France) at a 1/1000 dilution and incubation with an Alexa 488-conjugated anti-rabbit IgG secondary antibody (Molecular Probes, Eugene, OR, USA) used at a 1/1000 dilution. In situ hybridisation was performed on frozen sections using digoxigenin-labelled riboprobes as described previously (Guigon et al. 2003) . The mouse Cyp11a1 riboprobe (size 180 bp) was obtained after RT-PCR on mouse gonads and subcloning in pGEM-T Easy vector. Sense and antisense primers were 5 0 -GCACTTTGGAGTCAGTTTACATC-3 0 and 5 0 -AGGACGATTCGGTCTTTCTT-3 0 respectively. To identify gonadal structures, immunodetection of fibronectin was performed on the sections previously analysed or on adjacent sections using a rabbit anti-fibronectin antibody (dilution 1/100, ref F3648; Sigma). The TUNEL assay was performed on frozen ovary sections as described previously (Guigon et al. 2003) . Briefly, after thawing and rehydratation in PBS, the tissue sections were incubated for 1 h at room temperature with a mix containing fluorescein-deoxy-UTP (TUNEL Label; Roche Diagnostics) and terminal deoxynucleotidyl transferase (TUNEL enzyme; Roche Diagnostics). Detection of apoptotic cells was performed on the sections previously processed for cytochemical detection of ALPP. Images were captured using a Nikon Eclipse 90i microscope.
RNA preparation, reverse transcription, RT-PCR and real-time RT-PCR analyses
Total RNA from individual organs was extracted with the RNeasy Mini RNA extraction kit (Qiagen) and reverse transcribed using oligo-dT (Qiagen) and Superscript II reverse transcriptase (Invitrogen). Quantitative real-time RT-PCR was performed using the LightCycler 480 instrument and the LightCycler 480 SYBR Green I Master mix (Roche Diagnostics) according to the manufacturer's protocol. PCRs were performed using the primers listed in Table 1 . All primer pairs were tested before use for specificity and efficacy; only those that displayed an optimum efficacy (equal or superior to 1.8) were retained. The conditions for each real-time PCR were kept as follows: 10 min at 95 8C followed by 40 cycles of denaturation (10 s at 95 8C), annealing (10 s at 60 8C) and extension (10 s at 72 8C) with single acquisition of fluorescence at the end of each extension step. The specificity of real-time PCR products was confirmed by the analysis of the melting curve and agarose gel electrophoresis. Quantification of gene expression was performed using Relative Quantification Software (Roche Diagnostics), and data were expressed as a ratio of target gene to the reference gene Hprt. This reference gene was selected after comparison with Ppia (cyclophilin) and Eif4h (eukaryotic translation initiation factor 4H or Wbscr1) (O'Shaughnessy et al. 2002) , as the same results were observed using Hprt or Eif4h.
Adapted RT-PCR for the detection of very low levels of Gnrhr mRNA Classical RT-PCR was adapted for the identification of very low Gnrhr mRNA levels in the mouse testis. Briefly, total RNA extracted from the testis of adult mice was reverse transcribed using Superscript II with the Gnrhr mRNAspecific primer (RT) 5 0 -TCTAACCTTAAACCCTGCCTTG-3 0 .
PCR amplification was then performed using the forward (F) 5 0 -CTACTGCCTTCAATGCTTCCTT-3 0 and reverse (R) 5 0 -TAGCGAATGCGACTGTCATC-3 0 primers under conditions described previously (Moumni et al. 1994) . Amplifications were carried out for 40 cycles using programmes optimised for Gnrhr cDNA (20 s at 95 8C, 30 s at 62 8C and 45 s at 72 8C) with a final 10 min incubation at 72 8C. Two negative controls were systematically added, in which water replaced RNA during the RT preparation or cDNA during the PCR preparation.
Cell culture and transient transfection assays
LbT2 cells kindly provided by Dr Pamela Mellon (University of California, San Diego, CA, USA) were maintained in monolayer cultures using high-glucose DMEM supplemented with 10% foetal bovine serum and penicillin/streptomycin at 37 8C in humidified 5% CO 2 , 95% air. They were transiently transfected using Lipofectamine 2000 (Invitrogen) following a reverse transfection protocol in 96-well plates as described previously (Schang et al. 2013) . After 5 h transfection, cells were treated for 20 h with or without 10 ng/ml activin A (R&D, Minneapolis, MN, USA) or 150 ng/ml recombinant mouse follistatin (Biovision, Milpitas, CA, USA) followed by a 4 h treatment with an increasing concentration of the GnRH agonist triptorelin (Ipsen Biotech, Paris, France). Luciferase reporter constructs were based on the pGL3 basic vector (Promega Corporation). To facilitate comparison, numbering of Gnrhr promoters was relative to the adenine of the translation start codon considered at position C1. pLuc0.44 rat Gnrhr containing the proximal rat Gnrhr promoter (K475 to K32) as well as the pLuc minimal Prl promoter (K35/C35) was described previously (Pincas et al. 2001) . pLuc 0.45 mouse Gnrhr contained the mouse proximal promoter extending from K480 to K11. The promoter fragment was obtained by the amplification of mouse genomic DNA and inserted into the HindIII and XhoI sites of the modified pGL3 vector as described previously for the rat promoter (Pincas et al. 2001) . Two independent clones were selected, verified by sequencing, and tested in transient transfection assays. The mouse promoter fragment displayed 100% identical sequence to the one published by Albarracin et al. (1994) and contained GnRH-and activin-response elements. 
Statistical analysis
Real-time RT-PCR results are expressed as the meanGS.E.M. of at least three animals. Significant differences were established by one-way ANOVA using the computer program GraphPad Instat version 2.03 (GraphPad software, Inc., San Diego, CA, USA). When significant variations were found, the Tukey-Kramer multiple comparison test was performed. Differences were considered significant at P%0.05.
Results
Tissue and cell specificities of transgene expression in 3.3-and 1.1-Gnrhr mouse lines
We first examined the cell-specific activity of both the 3.3-and 1.1-kb Gnrhr promoters in the testis and ovary of mice as well as in the pituitary using in situ ALPP staining. As expected from our previous work, in the pituitary, both promoters directed the expression of the transgene in a subpopulation of cells ( Fig. 1A and B), previously identified as gonadotrope cells using co-immunodetection with anti-LH beta antibody (Granger et al. 2004) . By contrast, only the 3.3, as reported previously (Schang et al. 2011a ), but not the 1.1 kb promoter was able to direct the expression of the reporter gene in the testis. Staining was observed outside of the seminiferous tubules, in the interstitial tissue, most probably in Leydig cells ( Fig. 1C  and D) . Immunodetection of the steroidogenic enzyme HSD3b in the same sections ( Fig. 1E and F) confirmed this hypothesis and indicated that transgene expression occurred in a subset of the Leydig cell population. In the ovary, surprisingly, both promoters were totally inactive (illustrated for the 3.3 kb promoter in Fig. 1G , H, and I). Because atretic follicles have been reported to express GnRHR (Peng et al. 1994) , TUNEL analysis was further performed to identify these follicles (arrows in Fig. 1G and I). The results revealed that none of them displayed ALPP activity. Developmental profile of rat Gnrhr promoter activity in the testis: comparison with endogenous Gnrhr in mouse and rat testes The 3.3-Gnrhr mice were used to determine the ontogenetic expression pattern of the transgene in the testis. To this end, total RNA was extracted from the testes dissected at several stages starting from 17 dpc and ALPP mRNA levels quantified using real-time RT-PCR. As shown in Fig. 2A , ALPP mRNA levels decreased sharply, by more than 80%, after birth and reached the lowest values by the end of the first postnatal week. Expression of the transgene then remained at very low levels for more than 2 weeks. Then, from 30 to 35 days, mRNA levels increased continuously and significantly until adulthood.
We next compared the testicular expression of the transgene with Gnrhr endogenously expressed in mice. Surprisingly, in mouse testes, Gnrhr mRNA levels were unquantifiable by real-time RT-PCR whatever the developmental stage. They could only be detected in adapted RT-PCR (see Materials and methods) using Gnrhr-specific primers in the retrotranscription step (Fig. 2C) . This suggested that endogenous Gnrhr is duly expressed in the mouse testis, however, at a very low expression level, estimated to be about 180 times lower than in the adult pituitary. By contrast, similar experiments conducted using RNA from rat testes indicated that levels of Gnrhr mRNA were strikingly higher than those in the mouse and easily quantified by real-time RT-PCR (Fig. 2B) . Comparing the developmental expression profiles of ALPP in mice and of endogenous Gnrhr in rats revealed striking similarities ( Fig. 2A and B) . In both cases, gene expression displayed a biphasic profile, with high mRNA levels around birth, which first declined and then increased at the end of the pre-pubertal period. Rat promoter activity, as evidenced through ALPP expression in a mouse context, thus matched better with rat than mouse endogenous Gnrhr expression. 
Ontogenetic expression of ALPP and Gnrhr mRNA levels in the mouse and rat testis. Testes were removed from 17 dpc to 56 dpn mice (A) or from 20 dpc to 55 dpn rats (B). Total RNA was extracted and specific mRNAs quantified using real-time RT-PCR, as described in the Materials and methods section, with reference to Hprt for standardisation. Values are the meanGS.E.M. of at least three animals in each age group. Groups with different letters are significantly different (P!0.05). (C) Detection of very low levels of Gnrhr mRNA in mouse gonads by adapted RT-PCR (see Materials and methods). Top: schematic representation of the mouse Gnrhr showing a general intron/exon organisation with 3 0 and 5 0 -UTR (bold lines) flanking the coding sequence (boxed). Below are positioned the reverse transcription-specific primer (Rev.Transcrip.) and the forward (F) and reverse (R) primers used. I1, I2: introns 1 and 2; ATG: start codon of translation; STOP: stop codon of translation. Bottom: gel analysis of RT-PCR products amplified from the pituitary (Pit), testis and ovary RNA. To obtain quantitatively comparable signals, a calibration protocol was developed as follows: GnRHR-specific retrotranscription was performed in parallel in the presence of either 0.5 mg pituitary RNA, 0.5 mg ovary RNA or 2 mg testis RNA in the 20 ml reaction mix and 0.5, 1.5 and 3 ml respectively were used for subsequent PCR in a final 50 ml volume. Aliquots of 2, 6 and 15 ml from the pituitary, ovary and testis mixtures were loaded onto the gel. Accordingly, the material visualised on the gel is representative of RT-PCR from 90 ng testis RNA, 4.5 ng ovary RNA and 0.5 ng pituitary RNA. It represents roughly 180 times for the testis, and 9-10 times for the ovary, that from the pituitary. The expected size of the PCR product using F-R is 672 bp, whereas the smaller size (455 bp) represents the amplification of the truncated spliced variant naturally occurring through the deletion of the second exon (217 nucleotides long). DNA sequencing (Eurofins MWG Operon, Ebersberg, Germany) proved the identity of the material eluted from either band in accordance with mouse data bank sequences.
Similar biphasic profiles were observed when genes known to be involved in steroidogenic function in Leydig cells were quantified. Genes encoding Star and the enzyme steroid 17-alpha-hydroxylase/17,20 lyase (Cyp17a1) analysed in mice (Fig. 3A and C) and rats ( Fig. 3B and D) , as well as the LH receptor gene (Lhcgr) in mice (Fig. 3E) , were highly expressed at the end of foetal life (17 dpc in mice and 20 dpc in rats). They displayed strong decreases in expression at birth (from 75 to 85% decrease depending on the gene). The expression of these genes remained low during the pre-pubertal period and thereafter increased significantly until the adult life. These expression patterns probably reflected the differentiation and evolution of Leydig cells and specifically the transition between foetal and adult populations. This was further illustrated using marker genes of both populations, i.e. Thbs2 (encoding thrombospondin-2) for foetal Leydig cells and Hsd3b6 (encoding 3b-hydroxysteroid dehydrogenase isomerase type 6) for adult Leydig cells (O'Shaughnessy et al. 2002) . As illustrated (Fig. 3F ), Thbs2 expression declined soon after birth to reach undetectable levels after about 2 weeks of postnatal life, whereas, by contrast, Hsd3b6 expression was induced after 3 weeks of postnatal life.
In situ analysis of transgene expression in the developing mouse testis
To address the tissue localisation of transgene expression during development as well as to extend the analysis to early developmental stages, we performed an in situ ontogenetic study of Gnrhr promoter activity in the differentiating testis. ALPP activity could be detected as early as 12 dpc, i.e. at the very beginning of Leydig cell differentiation (O'Shaughnessy et al. 2006) . It is, however, worth noting that only a subset of Leydig cells identified by immunodetection of the steroidogenic enzyme HSD3b was positive for ALPP activity (cf. Figure 4A and C). In all subsequent stages during the foetal period, ALPP-positive cells became gradually more abundant (Fig. 4B ), but were markedly less than the Leydig cells expressing HSD3b (Fig. 4D) .
After birth, during the first postnatal week, ALPP-and HSD3b-positive cells were in similar proportion (cf. Figure 5A and B). These cells were roundish in form and most of them were organised in clusters that are typical of Leydig cells of foetal type (Kerr & Knell 1988 , Vergouwen et al. 1991 . During the second and third postnatal weeks, the number of ALPP-positive cells increased substantially ( Fig. 5C and F) and was higher than the number of Leydig cells identified by HSD3b activity (Fig. 5D and G) or Cyp11a1 transcript expression ( Fig. 5E and H) . At this period, in addition to roundish clustered cells (Fig. 5F , insert 2), a new type of ALPP-positive, but HSD3b-negative, cells had differentiated. These cells were spindle-shaped (Fig. 5F, insert 1) and not clustered, as were the roundish Leydig cells positive for HSD3b activity (Fig. 5G, insert) and Cyp11a1 expression (Fig. 5H, insert) . These cells are typical progenitors of the adult lineage (Benton et al. 1995) .
Comparison of transgene and Gnrhr expression in the pituitary during postnatal development and following castration in the adult Contrasting with the testis, in mouse pituitary, both transgene and Gnrhr mRNA were readily detected by realtime RT-PCR at all ages investigated, i.e. from the end of gestation to adult. Interestingly, the two profiles obtained in this tissue (Fig. 6A) were rather similar and 
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Figure 3
Ontogenetic expression of Star (A and B), Cyp17a1 (C and D), Lhcgr (E), Hsd3b6 and Thbs2 (F) mRNA levels in the mouse and/or rat testis. Specific mRNAs were quantified using real-time RT-PCR as described in the Materials and methods section with reference to Hprt for standardisation using the same pool of total RNA as in the Fig. 2A and B legend. Values are the meanGS.E.M. of at least three animals in each age group. Groups with different letters are significantly different (P!0.05).
markedly differed from the profile characterised in the testis (cf. Fig. 2A ). Indeed, in the pituitary, both ALPP and Gnrhr expression increased steadily during the first 3 postnatal weeks, and then a sharp drop occurred between days 24 and 34 and expression levels remained at an average value until adulthood. There was, however, a phase shift during a sharp period extending from 10 to 24 dpn, reflected first by a decline in rat promoter activity (ALPP) between 10 and 14 dpn and then by a rebound to 21 and 24 dpn, slightly offset to the endogenous Gnrhr pattern.
Because an important feature of the rat pituitary Gnrhr is its up-regulation following sex steroid depletion, we investigated whether this property might also be conveyed by the rat transgenic promoter. To this end, transgenic mice and rats were castrated and pituitary levels of ALPP and Gnrhr mRNA were measured in parallel. Figure 6B , C, D, E, and F illustrates the results obtained after 8 days of castration. As expected, castration up-regulated Gnrhr expression in the rat pituitary (Fig. 6B) . Surprisingly, such regulation was not observed in mice. Up-regulation of endogenous Gnrhr occurred neither in orchidectomised male (Fig. 6D) , nor in ovariectomised females (Fig. 6C) , further indicating that the lack of response was not gender dependent. In contrast, castration led to an increase in the expression of the gonadotropin subunit genes Lhb and Cga not only in rats but also in mice in both sexes (Fig. 6B, C , D, E, and F), validating the protocol and providing evidence for the response of pituitary gonadotrope cells in both species. Most importantly, and contrasting with the endogenous gene, a marked increase in transgene expression was simultaneously observed in the pituitary of castrated male and ovariectomised female mice. The same results were obtained with the 1.1-Gnrhr mouse line ( Fig. 6E and F) .
The rat promoter sequences, the long (3.3 kb) as well as the shorter one (1.1 kb), were thus able to direct gene expression in a species-specific manner, mimicking in the mouse environment the castration-induced responsiveness of the rat endogenous Gnrhr. These results not only reveal species specificity in response to the castration of the rat and mouse Gnrhr but also demonstrate that the up-regulation of the rat Gnrhr following castration is maintained in the mouse gonadotrope cell context. Moreover, comparison of data from the two transgenic models indicates that this regulation is mediated by response element(s) contained within the 1.1 kb sequence of the rat Gnrhr promoter.
Potential role of the activin/follistatin system in the differential pituitary response of the rat and mouse Gnrhr promoter following castration Among these response elements, the Gnrhr-activating sequence (GRAS) located at position K391/K380 (Duval et al. 1999 ) and the downstream activin regulatory element (DARE) located at position K366/K349 (Cherrington et al. 2005 ) mediate activin stimulation of the mouse Gnrhr. These two response elements are not conserved in the rat promoter, leading to the lack of activin up-regulation of the rat Gnrhr. We thus examined whether a differential interaction between GnRH and the activin/follistatin system may account for species-specific differences in response to castration. Experiments were conducted in vitro using the LbT2 gonadotrope cell line transiently transfected with the rat and mouse promoter luciferase fusion constructs (Fig. 7) . Transfected cells were pretreated or not for 20 h with activin A or follistatin and then treated for 4 h with an increasing concentration of the GnRH agonist triptorelin. Regarding the rat gene, GnRHa induced a strong and highly significant (P!0.001) increase in promoter activity (from 3.5-to 6-fold over control) whatever the concentration tested, with a maximum at 1 nM GnRHa. By contrast, the activity of the mouse promoter, under the same conditions, was not significantly stimulated (PO0.05). Conversely, the rat promoter was unresponsive to activin or follistatin, as expected, while the activity of the mouse promoter was strongly stimulated (P!0.001) following activin treatment. The mouse promoter also appeared to be sensitive to follistatin when cells were co-treated with 0.1 and 1 nM GnRHa. Furthermore, GnRHa dose-dependently decreased the response to activin stimulation.
Discussion
In the past years, many studies have focused on defining the molecular mechanisms underlying the cell-specific and regulated expression of GnRHR in the pituitary. This has led to the identification of specific response elements and gonadotrope-specific transcriptional repertoires (Hapgood et al. 2005) . These investigations concerned essentially the mouse, rat and human Gnrhr and were served by the two gonadotrope cell lines aT3-1 and LbT2, generated by targeted oncogenesis in P Mellon's group (Windle et al. 1990 , Alarid et al. 1996 , Thomas et al. 1996 . By comparison, only a few studies have characterised the mechanisms underlying Gnrhr promoter activity in extrapituitary tissues because of the lack of appropriate host cell lines. An alternative approach based on the generation of mouse models by additive transgenesis has been developed to complement these in vitro studies. In the present work, we took advantage of such transgenic mice to initiate the characterisation of rat Gnrhr promoter activity in the developing testis. In adulthood, we provided evidence that the 3.3 kb sequence of the rat Gnrhr promoter is able to direct testis-specific expression of the ALPP reporter gene. By contrast, the 1.1 kb promoter, although known to confer maximal pituitary activity (Granger et al. 2004) , was ineffective. In addition, we demonstrated that 3.3 kb promoter activity is restricted to Leydig cells, a cell specificity in agreement with previous data on GnRHR and Gnrhr mRNA in rats (Hapgood et al. 2005 ). This specificity is further emphasised by the fact that neither the 1.1 kb nor the 3.3 kb promoter is active in the ovary, suggesting the existence of additional regulatory sequences such as an alternative promoter in this tissue. Data obtained by two other groups using similar transgenesis approaches clearly support our results. Accordingly, McCue et al. (1997) and Duval et al. (2000) observed that the 2.7 kb ovine Gnrhr promoter or the 1.9 kb murine promoter directs gene expression in the pituitary and testis of transgenic mice but not in the ovary. Further, Albarracin et al. (1999) reported that the shorter 1.2 kb murine promoter is active in the pituitary but not in the testis. Together, these data indicate that the region between K1.2 and K1.9 kb of the mouse promoter is crucial for testis-specific expression. Consistently, comparison by dot matrix pairwise alignments of the 3 kb 5 0 upstream sequences of rat and mouse Gnrhr (Fig. 8A ) indicated that sequence identity was abruptly lost beyond base positions K2085 and K2094 respectively, suggesting that genomic sequence escaped from functional constraints beyond 2.1 kb in both rats and mice. We may therefore suggest that the promoter domain located between the ATG codon and K1.1 kb accounts for pituitary-specific expression and that the region located between K1.1 and K2.1 is needed for testis specification and accounts for species-specific differences in gene expression levels in the gonads. However, this upstream domain does not appear to be conserved in other mammalian species, namely in the human promoter. Indeed, sequence identities between human and rat (or mouse) promoters are lost beyond 1200 bp from the ATG codon (Schang et al. 2011a) . Further inspection of the Gnrhr loci indicates that several conserved non-coding sequences are present in the first intron. These constrained elements constitute additional candidates that may confer tissue-specific gene expression in testis, ovary or other extrapituitary tissues. The expression profiles of ALPP driven by the rat promoter in the mouse testis and of Gnrhr in the rat testis are strikingly correlated. Profiles of rat mRNA are consistent with initial studies co-authored by Huhtaniemi et al. (1985) identifying in the rat testis the highest concentration of GnRH-binding sites at day 1 of life, followed by a decline reaching a nadir at 15 dpn, and then a gradual increase until adulthood. Furthermore, the testis-specific patterns of rat Gnrhr expression and the transgene are in close concordance with the developmental pattern of several Leydig cell marker genes such as Lhgcr, Star and Cyp17a1. All these genes are known to be Intact (5) Orchidectomised (5) Intact (4) Ovariectomised (4) Intact (4) Orchidectomised (3) Intact (5) Orchidectomised (4) Intact (4) Ovariectomised ( expressed in both foetal and adult Leydig cell populations, recapitulating different phases of their differentiation (O'Shaughnessy et al. 2002) . Indeed, the first increase in the expression of these genes correlates well with Thbs2 expression, which typifies foetal Leydig cells. The second increase occurs around 20 dpn and correlates with the onset of Hsd3b6 expression that follows the initial differentiation of the adult Leydig cell population. This differentiation starts around day 10 and is associated with the proliferation of progenitors distinct from foetal Leydig cells. Studies on the Dhh-null mouse have now supported the hypothesis that foetal Leydig cells remain in the testis but are concealed by the development of a much greater adult population (Clark et al. 2000) . Alternatively, proliferation of other cell types, notably Sertoli cells, after birth may contribute to the change in the proportion of foetal Leydig cells (Baker & O'Shaughnessy 2001) . At these stages, Leydig cells in clusters and of round shape corresponding to the foetal population strongly co-express ALPP and HSD3b; the others, mostly of spindle shape, correspond obviously to differentiating adult Leydig cells, expressing Gnrhr but not yet HSD3b. This differs from foetal cells where the activity of the promoter appears concomitantly or posteriorly to the expression of HSD3b when the majority of cells are HSD3b positive/ALPP negative at 12 dpc. These data support the idea that Gnrhr, or its surrogate ALPP, could be a marker of adult Leydig cell progenitors. These testis-specific expression patterns appear clearly distinct from those previously observed in the foetal pituitary (Granger et al. 2004 (Granger et al. , 2006 . In the pituitary, we further show here that both ALPP and endogenous Gnrhr are co-expressed in a remarkably similar manner, notably during postnatal development. In their whole, pituitary profiles displayed a gradual increase of expression in the period before puberty to return later at a stable intermediate level. Such profiles are compatible with progressive differentiation and development of the gonadotrope cell lineage with the influence of hormonal regulation, especially at puberty (Wilson & Handa 1997 , Zapatero-Caballero et al. 2003 .
Importantly, we report here species-specific divergences between rat and mouse Gnrhr expression that are further underlined by the behaviour of the transgene in its mouse context. Contrasting with the Gnrhr gene in the rat testis and with the rat promoter ALPP fusion transgene in the mouse testis, the endogenous mouse Gnrhr is expressed at very low levels in the gonads. These data are consistent with previous works illustrating the lack of detection of GnRH-binding sites in the foetal (Pointis & Latreille 1986 ) as well as adult (Wang et al. 1983 ) mouse testis, the absence of functional consequences after Gnrhr disruption (Wu et al. 2010) and the low activity of the 1.9 kb mouse Gnrhr promoter in the testis of transgenic mice. Indeed, the latter was estimated to be about 1:100 Rat Gnrhr promoter 3.85× 3.68× 3.54×
1.34×
1.07×
1.32×
Figure 7
Comparative effects of activin A, follistatin and GnRH on rat and mouse Gnrhr promoter activities in LbT2 gonadotrope cells. LbT2 cells were co-transfected for 5 h with pRL-SV (internal control of transfection efficiency) together with the pLuc0.44 Gnrhr (K475/K32 rat promoter), pLuc0.45mo Gnrhr (K480/K11 mouse promoter) or pLucPrlmin (K35/C35) construct, incubated for 20 h in DMEM supplemented with 2% foetal bovine serum in the absence (black bars) or presence (light grey bars) of activin A (10 ng/ml) or follistatin (150 ng/ml, dark grey bars) and finally post-incubated for 4 h with a control medium or medium supplemented with activin or follistatin and containing or not (control) increasing concentrations of the GnRH agonist triptorelin (GnRHa) as indicated. Cells were then lysed and firefly and Renilla luciferase activities were determined. The highest concentrations of GnRH (10 nM) as well as activin treatment induced small but consistent increases in the activity of the minimal Prl promoter and of the empty pGL3 vector (not illustrated). These variations were considered as non-specific and results were therefore expressed as fold stimulation over minimal Prl promoter activities for each treatment. Values are the meanGS.D. of three to four independent experiments performed in triplicate. Indicated statistical comparisons for the rat Gnrhr promoter are those between the GnRH-treated vs untreated cells (control). The ones reported for the mouse promoter are those between the control or GnRH-treated cells vs activin or follistatin-treated or co-treated cells: ***P!0.001; **P!0.01.
that in the pituitary (McCue et al. 1997) , a value in the range found in the present study. The low expression of Gnrhr mRNA in the mouse testis is supported by the very faint labelling of Gnrhr mRNA subspecies identified by northern blot (Bull et al. 2000) . Interestingly, recent use of genetically engineered mice that either selectively ablated Gnrhr-expressing cells or expressed the yellow fluorescent protein under the endogenous Gnrhr promoter established that the mouse Gnrhr is not expressed in Leydig cells (Wen et al. 2010) . Some faint expression could, however, be Sequence identity between the two promoters is abruptly lost beyond K2085 and K2094 in rats and mice respectively. (B) Pairwise alignment of the testis-specific domains of rat and mouse Gnrhr promoters. In addition to some small sequence blocks that are lacking in one or the other promoter, the most important divergence is the presence of an AC/TG repeat (1477/1377) in the mouse sequence that is lacking in the rat sequence and partially replaced by a GATA repeat (1446/1393).
detected in germ cells postnatally, supporting data from Bull et al. on purified germ cells. The recent work of Anjum et al. (2012) reporting strong immunoreactivity in both Leydig and germ cell populations may reflect a peculiar trait of the strain used, i.e. the Parkes mice. Alternatively, the immunoreactive material detected may not be representative of functional GnRHR. Thus, the majority of the evidence implies that rats and mice display clear-cut differences in GnRHR expression notably in Leydig cells, suggesting potentially important functional differences in the rat vs mouse genomic sequence. In this regard, it is worth noting that an AC/GT repeat ((AC) 14 AT (AC) 15 ) is exclusively present in the mouse sequence at position K1477/K1377 (Fig. 8) . In at least two other promoters, those of the haem oxygenase I gene and of the von Willebrand factor gene, variations in the length of these AC/GT repeats are correlated with various human diseases that are thought to be linked to variations in promoter activities (Daidone et al. 2010 , Bean et al. 2012 . This repeat may therefore contribute to severe attenuation of mouse promoter activity. Similarly, some blocks of the sequence are lacking in one or the other promoters that might have an impact on gene expression levels, the larger one being located at positions K1900/K1881 in the rat sequence (Fig. 8B ). This marked difference in mouse and rat promoter activities in the testis is reminiscent of our previous observations in the hippocampus where similar divergence between those two promoter activities was identified (Schang et al. 2011b) . In both cases, the rat transgenic promoter displays the same behaviour during embryonic and postnatal development as the rat endogenous Gnrhr, despite the mouse context. Together, these data are consistent with a predominant role of genetic information over cell context in species-specific variations of Gnrhr expression. This is further highlighted by castration experiments. Castration is a widely used model known to induce the up-regulation of Gnrhr and other genes such as Lhb and Cga (Gharib et al. 1990 , Counis 1999 . Such regulation is mainly due to the removal of the negative feedback mediated by gonadal steroids on GnRH secretion, leading ultimately to enhanced stimulation of pituitary gonadotrope cells (Herbison 1998) . In adult mice, in contrast with rats, the castration-induced rise in GnRH secretion duly up-regulates gonadotropin subunit genes but not Gnrhr expression. This is illustrated here 8 days after castration, but was also observed after 15 days (not illustrated). Gnrhr expression was not evaluated over a longer period of time, and it remains possible that some changes may occur later. However, studies from Clayton's group (Naik et al. 1984a,b) reported, using radio-receptor assays, the absence of an increase in the number of GnRHR in both male and female mice for at least 2 months after castration. Our in vitro experiments using the LbT2 gonadotrope cells transiently transfected with the rat and mouse promoter luciferase fusion constructs likewise illustrate the differential responsiveness of the mouse and rat pituitary Gnrhr to GnRH stimulation. Indeed, rat but not mouse Gnrhr promoter activity was significantly increased by GnRH stimulation. This might be explained by activin/ follistatin-dependent mechanisms. Indeed, in normal pituitary gonadotrope cells as well as in LbT2 cells, GnRH stimulates follistatin gene (Fst) expression (Winters et al. 2007 ) and Fst expression is increased in rat pituitaries following gonadectomy (Kaiser & Chin 1993 , Dalkin et al. 1998 . Follistatin has been shown to down-regulate mouse Gnrhr transcription, most probably by counteracting the action of endogenous activin (Duval et al. 1999 , Pernasetti et al. 2001 . Accordingly, GnRH dose-dependently decreased mouse promoter responsiveness to activin stimulation probably through follistatin-mediated activin neutralisation (Fig. 7) . By contrast, the rat Gnrhr promoter, which is not sensitive to activin due to the lack of activinresponse elements, was not influenced by follistatin treatment ( Fig. 7 ; Cherrington et al. 2005) . Altogether these data suggest that divergent responses to castration in the rat and mouse species occur via follistatin that might counterbalance GnRH up-regulation of Gnrhr mRNA in the mouse but not in rat pituitary. The positive response elicited by the rat transgenic promoter in the mouse context is instructive and suggests that, as in the gonads, the species-specific characteristics are encoded into the promoter sequences rather than being dictated by the physiological or cellular environment. Altogether our studies in transgenic mice using two distinct conditions and distinct tissues demonstrate that the activity of endogenous Gnrhr, on the one hand, and of a transgene driven by a foreign Gnrhr promoter, on the other hand, may vary in a divergent, independent manner. In this case, the transgene behaves with respect to the species origin and properties of the driving promoter.
In conclusion, this study shows that the rat promoter is activated in foetal as well as adult Leydig cell progenitors and strongly suggests that the rat Gnrhr is a marker of Leydig cell differentiation. Secondly, the tissue-specific elements required for directing Gnrhr expression in these progenitor cells as well as in differentiated Leydig cells are most probably circumscribed to the 2 kb promoter region 5 0 upstream of the ATG codon.
Third, and most importantly, our study points out the inter-species variations in the level of Gnrhr activity in the testis and its regulation in the pituitary, and thus underlines the predominant influence of intrinsic information encoded into the promoter sequence. In this regard, this study supports the recent concept developed by Wilson et al. (2008) that in homologous tissues, the genetic sequence is mainly responsible for directing transcriptional programmes.
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